FOSTER CITY (KCBS) – The University of California is testing a potential HIV prevention pill in a first-of-its-kind study in the state.
The UC-based California HIV/AIDS Research Program (CHRP) has awarded grants totaling $11.8 million to see if a current HIV drug can be used to prevent the onset of the virus.
The antiretroviral pill Truvada, made by Foster City-based Gilead Sciences, Inc., was approved by the United States Food and Drug Administration in 2004 to treat HIV patients. An international trial has shown it works as a preventive measure in select gay and bisexual populations, according to Dr. George Lemp, the director of CHRP. Read More
Posted by
Master
on Friday, April 20, 2012
0 comments:
Post a Comment